Predictive marker of responsiveness of anemia in non-dialytic CKD to long acting erythropoiesis stimulating agent

Predictive marker of responsiveness of anemia in non-dialytic CKD to long acting erythropoiesis stimulating agent - Responsivenss of CKD anemia for long acting ESA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006494

Enrollment

100

Registered

2011-10-07

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-dialytic chronic kidney disease

Interventions

long acting erythropoiesis stimulating agent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Anemia (hemoglobin < 11.0g/dL in more than two measurement) due to chronic kidney disease

Exclusion criteria

Exclusion criteria: 1 Severe hypertension 2 Congestive heart failure (NYHE III or IV) 3 Myocardial infarction, pulmonary infarction of cerebral infarction within 6 months 4 Active infection 5 Malignant tumor and hematological disease 6 erythropoietin use within 6 months 7 Transfusion within 6 months 8 Patients whom doctor judged inappropriate as participant

Design outcomes

Primary

Measure	Time frame
Increase in hemoglobin after 8 weeks from starting ESA	—

Secondary

Measure	Time frame
Increase in hemoglobin above the level at which ESA is recommended to stop in the guideline	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026